BRAF-Mutation detection in metastatic Melanoma

被引:6
作者
Dietel, M. [1 ]
Enk, A. [2 ]
Lehmann, A. [1 ]
Bauer, J. [3 ]
Garbe, C. [3 ]
Kellner, U. [4 ]
Kirchner, T. [5 ]
Jung, A. [5 ]
Kreipe, H. [6 ]
Merkelbach-Bruse, S. [7 ]
Buettner, R. [7 ]
Rueschoff, J. [8 ]
Schlake, W. [9 ]
Schirmacher, P. [10 ]
Penzel, R. [10 ]
Stadler, R. [11 ]
机构
[1] Charite, Inst Pathol, Charite, D-10117 Berlin, Germany
[2] Univ Heidelberg, Haut Klin, D-6900 Heidelberg, Germany
[3] Univ Tubingen, Sekt Dermatol Onkol, Haut Klin, D-72074 Tubingen, Germany
[4] Johannes Wesling Klinikum, Inst Pathol, Minden, Germany
[5] LMU, Inst Pathol, Munich, Germany
[6] Hannover Med Sch, Inst Pathol, Hannover, Germany
[7] Univ Klinikum Koln, Inst Pathol, Cologne, Germany
[8] Inst Pathol Nordhessen, Kassel, Germany
[9] Pathol & Gewerbepathol Inst, Gelsenkirchen, Germany
[10] Univ Heidelberg, Inst Pathol, D-6900 Heidelberg, Germany
[11] Johannes Wesling Klinikum, Haut Klin, Minden, Germany
来源
PATHOLOGE | 2012年 / 33卷 / 04期
关键词
VEMURAFENIB; SURVIVAL; CANCER;
D O I
10.1007/s00292-012-1609-5
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
[No abstract available]
引用
收藏
页码:352 / 356
页数:5
相关论文
empty
未找到相关数据